Kenyan court rejects Rastafarian cannabis plea, leaving religious-freedom fight in the appeal courts

At the Milimani Law Courts in Nairobi on 15 July 2026, a magistrate refused to grant Kenyan Rastafarians the right to use cannabis as a sacrament, dismissing their petition and urging the country's parliament to hold a national debate on drug policy. The bench acknowledged, in the same ruling, that the question of whether ganja should be legalised in Kenya cannot be settled by the courts alone.

The judgment is a setback for a community that has argued, in filings and hearings stretching back more than a decade, that the herb central to their worship is protected by the right to freedom of religion guaranteed in Kenya's constitution. The petitioners have signalled they will appeal; the case now moves up the ladder, with the legal bill picked up by a coalition of civil-society lawyers who have spent years building the file.

What the court actually said

The petition asked the court to read down sections of the Narcotic Drugs and Psychotropic Substances Act, the 1994 statute that criminalises possession and use, on the grounds that criminalising sacramental cannabis breaches the constitutional right to manifest religion. The bench declined, and in doing so drew a familiar line: religious freedom is not absolute, and the state has a legitimate interest in regulating psychoactive substances.

The ruling, as reported, did not reject the underlying grievance. It pushed the harder questions to the National Assembly and the Senate, telling legislators that the country needs a fuller debate on cannabis policy, including the medical, economic and criminal-justice dimensions that have been parked since the colonial-era drug law was tightened in the 1990s. The court also stopped short of endorsing a blanket ban, leaving the door open to a future challenge grounded in different facts.

For Kenya's roughly half a million Rastafarians, organised through groups including the Rastafarian Society of Kenya and the Kenyan Rastafari Community, the practical effect is immediate. Members who use the herb in worship remain exposed to arrest, prosecution and the social stigma that attaches to a drugs charge.

A community that has been here before

This is not the first time Kenyan Rastafarians have tested the constitutional settlement on the herb. Earlier rounds of litigation produced mixed results, including a 2018 High Court decision that declined to grant the exemption while acknowledging the sincerity of the community's belief. The pattern matters: each petition has been heard, each has produced a reasoned judgment, and each has left the underlying prohibition intact.

The community's argument is older still. Rastafarians arrived in Kenya in the early twentieth century, brought by the construction of the Uganda Railway and by broader Caribbean migration, and have worshipped openly for decades. The herb, sacred in the tradition, sits at the heart of ceremonies; possession of even small amounts can mean a charge that carries a sentence of up to twenty years under the existing law. The petitioners say the criminal exposure itself is the injury, regardless of whether prosecutions are routine.

The regional picture is shifting underneath the case

While Nairobi's courts have been cautious, the wider East African map is moving. Lesotho became the first African country to legalise the cultivation and sale of medical cannabis in 2017, and has courted foreign investment to build an export-oriented industry around the crop. Uganda and Zimbabwe have followed with their own medical-cannabis frameworks, and Rwanda has courted foreign capital to set up processing for export. South Africa has gone further, with a Constitutional Court ruling in 2018 that personal use in private is lawful, even as commercial trade remains heavily restricted.

Kenya, by contrast, has stayed on the prohibition side. Parliament has talked about medical-cannabis regulation for years without producing a bill. The court is now, in effect, asking the political class to take the question seriously, and naming the cost of continued delay: an unresolved collision between the constitution's religious-freedom guarantee and a statute the bench has no appetite to rewrite by judicial fiat.

There is also an economic subtext the petitioners have pressed in hearings. The legal Kenyan cannabis market, on the most conservative industry estimates, would generate tax revenue and displace the parallel trade that funds organised crime across the East African corridor. Civil-society lawyers backing the community have made that case in the same filings in which they cite the constitutional injury, hoping to broaden the political coalition for reform beyond a single religious group.

What the appeal will turn on

An appeal is expected to be lodged in the coming weeks, and the appellate bench will face a narrower question than the one the magistrate answered: not whether cannabis should be legalised, but whether the constitution requires a religious exemption until the legislature acts. The community's lawyers are likely to lean on comparative jurisprudence from the African Court on Human and Peoples' Rights, which has read the right to religion broadly, and on South Africa's constitutional reasoning in the 2018 ruling, which the petitioners have previously cited as persuasive authority.

The state's counter-position is straightforward. Kenya is a signatory to the UN Single Convention on Narcotic Drugs and its successor protocols, and the government has consistently argued that international treaty obligations constrain domestic policy. The bench that heard the petition appeared to accept that framing, even while inviting parliament to revisit it. An appeal will test whether the appellate court reads those obligations as a hard ceiling, or as a policy choice the state can revisit.

What remains uncertain

The sources do not specify when the appeal will be filed, or which bench will hear it. They do not name the specific magistrate who delivered the 15 July ruling. The reported reaction from the Rastafarian community is one of disappointment and a stated intention to appeal, but the community has not, on the public record, signalled a broader civil-disobedience campaign if the appeal also fails. Nor is there reporting yet on whether the National Assembly's Health Committee intends to take up the court's implicit invitation to convene hearings on cannabis reform. The most that can be said is that a constitutional question the bench has refused to answer is now back in the political arena, with all the uncertainty that implies.

Desk note: Monexus is treating the ruling as a judicial event with a live political tail, not as a final word. The wire framing has emphasised the religious-freedom angle; Monexus is foregrounding the drug-policy angle the bench itself flagged, since that is where any durable change will have to be made.